$49.74
1.24%
NYSE, Aug 22, 10:00 pm CET

QIAGEN NV Stock price

$49.74
+0.23 0.46% 1M
+9.83 24.63% 6M
+3.94 8.60% YTD
+1.69 3.51% 1Y
-0.02 0.05% 3Y
-5.00 9.13% 5Y
+21.95 78.96% 10Y
+36.09 264.28% 20Y
NYSE, Closing price Fri, Aug 22 2025
+0.61 1.24%

Key metrics

Basic
Market capitalization
$10.8b
Enterprise Value
$11.3b
Net debt
$490.2m
Cash
$953.8m
Shares outstanding
216.8m
Valuation (TTM | estimate)
P/E
29.3 | 20.8
P/S
5.3 | 5.1
EV/Sales
5.5 | 5.4
EV/FCF
22.7
P/B
3.1
Dividends
DPS
$1.55
Yield 1Y | 5Y
3.1% | 1.2%
Growth 1Y | 5Y
13.9% | -
Payout 1Y | 3Y
357.2% | 35.6%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$2.0b | $2.1b
EBITDA
$546.4m | $787.5m
EBIT
$538.7m | $610.4m
Net Income
$373.4m | $519.4m
Free Cash Flow
$496.0m
Growth (TTM | estimate)
Revenue
5.2% | 6.4%
EBITDA
18.6% | 56.1%
EBIT
19.8% | 23.3%
Net Income
413.6% | 521.3%
Free Cash Flow
22.4%
Margin (TTM | estimate)
Gross
63.7%
EBITDA
26.8% | 37.4%
EBIT
26.4%
Net
18.3% | 24.7%
Free Cash Flow
24.3%
Financial Health
Equity Ratio
62.7%
Return on Equity
2.3%
ROCE
11.5%
ROIC
-
Debt/Equity
0.4
More
EPS
$1.7
FCF per Share
$2.3
Short interest
4.5%
Employees
5k
Rev per Employee
$380.0k
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a QIAGEN NV forecast:

14x Buy
58%
10x Hold
42%

Analyst Opinions

24 Analysts have issued a QIAGEN NV forecast:

Buy
58%
Hold
42%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,040 2,040
5% 5%
100%
- Direct Costs 740 740
3% 3%
36%
1,300 1,300
6% 6%
64%
- Selling and Administrative Expenses 569 569
0% 0%
28%
- Research and Development Expense 185 185
5% 5%
9%
546 546
19% 19%
27%
- Depreciation and Amortization 7.77 7.77
28% 28%
0%
EBIT (Operating Income) EBIT 539 539
20% 20%
26%
Net Profit 373 373
414% 414%
18%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Positive
Seeking Alpha
3 days ago
Diagnostics now outperform Life Sciences due to academic funding cuts, making Qiagen's defensive profile more attractive in the current market. Qiagen offers stable growth, high profitability, and low leverage, providing a resilient investment option amid sector volatility and macroeconomic uncertainty. While Qiagen is a strong short-term buy, investors should also consider peers like SysMex, B...
Neutral
Seeking Alpha
18 days ago
Qiagen N.V. (NYSE:QGEN ) Q2 2025 Earnings Conference Call August 6, 2025 9:30 AM ET Company Participants John Gilardi - Vice President of Corporate Communications & Investor Relations Roland Sackers - CFO, MD & Member of Management Board Thierry Bernard - CEO, MD & Member of Management Board Conference Call Participants Aisyah Noor - Morgan Stanley, Research Division Casey Rene Woodring - JPMor...
Neutral
Business Wire
19 days ago
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced solid results for Q2 2025 that exceeded the outlook, and increased the full-year 2025 outlook for net sales growth while reaffirming the adjusted diluted earnings per share (EPS) target that was raised earlier in the year. Net sales rose 7% to $534 million compared to Q...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,232
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today